Elsevier,
Improving Sustainable Viticulture and Winemaking Practices, 2022, Pages 1-24
This book chapter advances SDGs 12 and 15 by explaining how the wine sector must implement more sustainable practices to mitigate climate change impacts and to decrease its environmental impact while ensuring its important economic and social function. This chapter presents and discusses the most relevant risks and concerns of modern wine industry and major sustainability issues related to wine production and related supply chain.
Elsevier,
Epigenetics of Stress and Stress Disorders, Volume 31 in Translational Epigenetics, 2022, Pages 137-162
Reviews the literature on the epigenetics of PTSD and interpret findings through the lens of understanding the implications for adverse physical health outcomes. The goal of SDG target is to cover treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders.
Elsevier,
Diabetic Neuropathy, 2022, Pages 1-9
Diabetic neuropathy is the most debilitating complication that can cause significant morbidity and mortality in type 1 and type 2 diabetic patients. It is essential to detect symptoms or signs of diabetic neuropathy and determine risk factors as early as possible to implement interventions and to prevent further neuronal damage. The goal of SDG 3.4 is to reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being 3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
Elsevier,
Fertility, Pregnancy, and Wellness, 2022, Pages 1-19
The relationship between healthy lifestyles and wellbeing, especially focused on women and pregnancy, continues to grow to understand and determine factors connected to chronic disease and to decrease them. Supports SDG target: 3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births
Microneedles, 2022, Pages 115-138
The sampling of interstitial fluid for real-time assay requires techniques that are sensitive, rapid, painless, minimally invasive and easy to use by patients. Microneedles can be incorporated into biosensors with subsequent use of these platforms for continuous monitoring or bio-chemical detection of analytes in the dermal interstitial fluid. Supports the goal of SDG 3.8 to achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.
Diabetes Without Needles, Non-invasive Diagnostics and Health Management, 2022, Pages 27-92
Introduces diabetes including past, present, and future achievements in this field. The goal of SDG target 3.4.1 is to reduce the mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
Elsevier,
Emerging Freshwater Pollutants. Analysis, Fate and Regulations, 2022, Pages 119-135
Links to SDG6 and the theme of WWD as it covers the presence of emerging pollutants in aquatic systems such as rivers, lakes, groundwater, glaciers, wetlands, the ocean poses significant risks to human and environmental health.
Elsevier,
Not Just Bad Kids, The Adversity and Disruptive Behavior Link 2022, Pages 569-594
This chapter advances SDGs 3, 4, and 10 by exploring topics with emphasis on the benefits and challenges of talking with youth about race and identity, strategies for coping, and ways that we can help promote racial healing in ourselves and our communities.
Clinical Ophthalmic Genetics and Genomics, 2022, Pages 457-463Gallie
Understanding the genetics of retinoblastoma has enabled clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk. The goal of SDG target 3.d is to strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risk.
